Next-Gen Fluoroscopy System vs Conventional System in Endoscopy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares radiation exposure between a next-generation fluoroscopy system and a conventional fluoroscopy system during fluoroscopy-guided endoscopic procedures. Procedures include ERCP, interventional EUS, stricture dilation, and related endoscopy tasks where ionizing radiation is used. The study aims to determine if the newer system reduces patient and provider radiation dose while maintaining procedural effectiveness. The trial is conducted at Orlando Health, with adult patients and involved clinical staff qualified to participate in fluoroscopy-guided endoscopy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Patients undergoing fluoroscopy-guided endoscopic procedure
* Physicians and anesthesia staff participating in endoscopic procedures

Exclusion Criteria:

* Age \< 18 years
* Pregnancy

Where it's running

• Orlando Health Digestive Health Institute
  Orlando, Florida, United States Recruiting

Study contacts

• Principal investigator: Ji Young Bang — Orlando Health
• Study coordinator: Ji Young Bang
• Email: jiyoung.bang@orlandohealth.com
• Phone: 321-842-2273

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Operator radiation dose during PCI: left distal radial access vs right conventional radial access

  This study tests whether using the left distal radial approach during PCI leads to different radiation exposure for the operator compared with the standard right radial approach in adult patients.

  Recruiting Yonsei University · Osaka and 3 other locations · NCT07579169

• Skipping the clinical target volume (CTV) around the primary tumor in limited-stage small cell lung cancer

  This trial tests whether giving chest radiotherapy that skips the usual extra margin around the main tumor is as effective and causes fewer side effects for people with limited-stage small cell lung cancer who have responded to initial chemotherapy.

  Recruiting at 2 sites Phase 3 Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07008716

• Reducing radiation exposure in the heart cath lab using RAMPART

  This study will test whether the RAMPART device reduces radiation exposure for doctors and nurses during coronary catheter procedures and allows them to wear lighter or no lead protection.

  Recruiting Liverpool Heart and Chest Hospital NHS Foundation Trust · Liverpool · NCT06875583

• Evaluation of ultra low dose CT scans with Iomeron 400 contrast

  This study is testing if using ultra low dose CT scans with a special contrast dye can help find lung problems like blood clots, cancer, and pneumonia while keeping radiation exposure low.

  Recruiting University of Zurich · Zurich · NCT06360627

• Registry of patients treated with heavy particle therapy for cancer

  This study is collecting information from cancer patients treated with advanced heavy particle therapy to see how well it works and what side effects it might cause.

  Recruiting CNAO National Center of Oncological Hadrontherapy · Pavia · NCT05203250

• Comparing two methods for catheter ablation of atrial flutter

  This study is testing whether a new way of doing catheter ablation for atrial flutter can be safer and more effective than the standard method.

  Recruiting Klinikum-Fuerth · Fürth, Bavaria · NCT04678258

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.